We have also supplemented this experience with assignments with leading contract research and contract sales organizations, as well as selected strategic engagements with specialized providers and payers.
Finally, Frankel Group has been engaged by the leading investment firms for both due diligence and post investment business advisory services. The range of these assignments has enabled Frankel Group to approach strategic issues from a more holistic delivery-of-care value creation basis, where ‘win-win’ solutions and industry aligned partnerships often result.
We have had the pleasure of supporting and advising the world’s leading pharmaceutical and medical device companies over the years (i.e. 4 of the top 5 pharmaceutical and device companies within the last 3 years). However, equally as important, the Firm has also consulted to, and invested in, emerging players in the biotechnology, pharmaceutical, medical device and diagnostics arena.
Within our client companies, we have served a broad range of organizational levels from CEO/Executive Team to Vice President’s to Director level personnel. Functionally, we have been actively involved with Strategic Planning, Preclinical Research/Clinical Research, Business Development/LM&A, Marketing/Sales/Account Management and Market Research.